Actively Recruiting
Evaluating a Non-Invasive Support Tool to Remove or Refine Antibiotic Allergy Labels in Hospitalized Adults
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2025-12-16
3000
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a non-invasive clinical decision support tool called the AAL-fact-check to address antibiotic allergy labels AAL, which are common in hospitalized patients, especially for beta-lactam antibiotics. These labels often lead to longer hospital stays and use of broader-spectrum antibiotics. This multicenter study aims to compare this new tools impact on antibiotic selection, clinical outcomes, antimicrobial use, and economic factors against standard care without the tool. The study involves two groups one using the AAL-fact-check tool, which includes a semi-automated electronic patient record EPR search for antibiotic re-exposure, and a standard care group without this tool. The AAL-fact-check process is strictly non-invasive and relies on questionnaires, medical file reviews, and contact with primary care providers to refine or remove allergy labels. Participants are followed up to 100 days after hospital discharge to assess various outcomes. Participants will have their antibiotic use and allergy labels reviewed, and clinical recovery, hospital stay length, mortality, infections, and costs will be monitored through hospital records and follow-up assessments. The primary outcome is the use of first-line antibiotics up to 100 days post-discharge. Secondary measures include antibiotic tolerance, need to switch antibiotics, infection rates, and economic evaluations. The total observation period extends up to 100 days after discharge, allowing detailed assessment of the tools impact.
CONDITIONS
Brief Title
Support Tool for Antibiotic Allergy deLabeling
Research Team
L
Liesbeth Gilissen, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here